Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 1, January-February, p. 77–82

doi: 10.17219/acem/61003

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Relationship of lipoprotein lipase gene variants and fasting triglyceride levels in a pediatric population: The CASPIAN-III study

Roya Kelishadi1,A,B,C,D,E,F, Mahin Hashemipour2,A,B,D,F, Behnoosh Esteki1,A,B,D,F, Mohammad Hasan Tajadini3,A,B,C,D,E,F, Laleh Rafiei3,A,B,C,D,E,F, Mohammad Esmaeil Motlagh4,A,B,D,F, Golnaz Vaseghi3,A,B,C,D,E,F, Gelayol Ardalan1,A,B,D,F, Shaghayegh Haghjooy Javanmard3,A,B,D,F

1 Pediatrics Department, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

2 Alzahra Hospital, Pediatrics Department, School of Medicine, Isfahan University of Medical Sciences, Iran

3 Physiology Department, Applied Physiology Research Center, Isfahan University of Medical Sciences, Iran

4 Pediatrics Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Background. Lipoprotein lipase (LPL) is one of the major enzymes responsible for the hydrolysis of triglyceride (TG)-rich lipoprotein. The effects of LPL polymorphisms on serum TG are inconsistent among different populations.
Objectives. This study aims to assess the TG serum concentration and distributions of three LPL single nucleotide polymorphisms (SNPs), namely D9N, HINDIII and S447X, in a nationally representative sample of Iranian adolescents.
Material and Methods. We studied the associations between SNP genotypes and TG levels in a nationally representative sample of Iranian adolescents. Genotyping was performed in 750 randomly selected participants. We compared the genotypes according to different TG levels.
Results. This study comprised 746 participants, with mean ± SD age of 14.6 ± 2.5 years. The distribution of genotypes of D9N and S447X were not significantly different according to TG levels. Regarding the HINDIII polymorphism, the distribution of GG, GT, and TT genotypes were significantly different in participants with low, borderline-high, and elevated TG (p = 0.02, 0.03, and 0.01, respectively). The mean TG was not significantly different according to the genotype distribution.
Conclusion. In this study, most of the LPL gene variants were not significantly different in adolescents with normal and elevated TG, and the mean TG was not different in participants with various genotypes. As the first evidence from the pediatric population of the region of the Middle East and North Africa (MENA), these results might be used in international comparisons. Our findings might suggest that the high prevalence of hypertriglyceridemia in Iranian adolescents is more likely to be a result of lifestyle rather than genetic factors.

Key words

single nucleotide polymorphisms, adolescence, triglycerides, lipoprotein lipase

References (35)

  1. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299–303.
  2. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008;300(18):2142–2152.
  3. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466(7307):707–713.
  4. Johansen T, Kathiresan S, Hegele R. Genetic determinants of plasma triglycerides. J Lipid Res. 2011;52(2):189–196.
  5. Kobayashi J, Mabuchi H. Lipoprotein lipase and atherosclerosis. Ann Clin Biochem. 2015;52(6):632–637.
  6. Li Y, He PP, Zhang DW, et al. Lipoprotein lipase: From gene to atherosclerosis. Atherosclerosis. 2014;237(2):597–608.
  7. Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol. 2011;22(4):247–253.
  8. Ramasamy I. Recent advances in physiological lipoprotein metabolism. Clin Chem Lab Med. 2014;52(12):1695–1727.
  9. Sabatti C, Service SK, Hartikainen A, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet. 2009;41(1):35–46.
  10. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189–197.
  11. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2009;41(1):47–55.
  12. Hajat C, Shather Z. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population. Diabetes Res Clin Pract. 2012;98(3):481–486.
  13. Al-Daghri NM. Extremely high prevalence of metabolic syndrome manifestations among Arab youth: A call for early intervention. Eur J Clin Invest. 2010;40(12):1063–1066.
  14. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092–1097.
  15. Kelishadi R, Ardalan G, Adeli K, et al. Factor analysis of cardiovascular risk clustering in pediatric metabolic syndrome: CASPIAN study. Ann Nutr Metab. 2007;51(3):208–215.
  16. Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014;1841(7):919–933.
  17. Kelishadi R, Heshmat R, Motlagh ME, et al. Methodology and early findings of the third survey of CASPIAN study: A national school-based surveillance of students’ high risk Behaviors. Int J Prev Med. 2012;3(6):394–401.
  18. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics. 2011;128(Suppl 5):
  19. Jap TS, Jenq SF, Wu YC, Chiu CY, Cheng HM. Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan. Pancreas. 2003;27(2):122–126.
  20. Nakamura MT, Yudell BE, Loor JJ. Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res. 2014;53:124–144.
  21. Benlian P1, Foubert L, Gagné E, et al. Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency. Am J Hum Genet. 1996;59:431–436.
  22. Yang T1, Pang CP, Tsang MW, et al. Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertrigyceride typ2 diabetes. Hum Mutat. 2003;21(4):453–463.
  23. Razzaghi H, Aston CE, Hamman RF, Kamboh MI. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyc-eride/low HDL-cholesterol levels. Hum Genet. 2000;107(3):257–267.
  24. Hu Y1, Ren Y, Luo RZ, et al. Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 dia-betic pedigrees. J Lipid Res. 2007;48(8):1681–1688.
  25. Tang W, Apostol G, Schreiner PJ, Jacobs DR, Jr, Boerwinkle E, Fornage M. Associations of lipoprotein lipase gene polymorphisms with longi-tudinal plasma lipid trends in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Genet. 2010;3(2):179–186.
  26. Hallman DM, Groenemeijer BE, Jukema JW, Boerwinkle E, Kastelein JJ. Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci. Ann Hum Genet. 1999;63:499–510.
  27. Rebhi L, Kchok K, Omezzine A, et al. Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population. Mol Biol Rep. 2012;39(11):9893–9901.
  28. Goodarzi MO, Guo X, Taylor KD, et al. Determination and use of haplotypes: Ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med. 2003;5:322–327.
  29. Daoud MS Ataya FS, Fouad D, Alhazzani A, Shehata AI, Al-Jafari AA. Associations of three lipoprotein lipase gene polymorphisms, lipid pro-files and coronary artery disease. Biomed Rep. 2013;1(4):573–582.
  30. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161–169.
  31. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein recep-tor-related protein. Proc Natl Acad Sci USA. 1991;88(19):8342–8346.
  32. Jensen MK, Rimm EB, Rader D, et al. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am Heart J. 2009;157(2):384–390.
  33. Komurcu-Bayrak EA, Onat A, Poda M, et al. The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. Clin Chim Acta. 2007;383(1):110–115.
  34. Doevendans PA, Jukema W, Spiering W, Defesche JC, Kastelein JJ. Molecular genetics and gene expression in atherosclerosis. Int J Cardiol. 2001;80(2–3):161–172.
  35. Higgins LJ, Rutledge JC. Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase. Curr Atheroscler Rep. 2009;11(3):199–205.